Endometriosis is a chronic oestrogen-dependent inflammatory disease characterised by the presence of endometrial tissue outside the uterine cavity. There is currently no cure for endometriosis. Here, the Inventors demonstrated in vivo that targeting CD73 significantly alters the development of endometriosis. These results thus demonstrate the relevance of CD73 as a therapeutic target in endometriosis.